Karen Pignet is the founder of Genespire. Genespire has raised $52M in total funding. Latest round: Series B.
Karen Pignet is the co-founder and CEO of Genespire, an Italy-based biotechnology company focused on developing gene therapies for rare pediatric genetic conditions. She was appointed CEO following the company's €46.6M Series B financing round in September 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library